UTICA, N.Y.–(BUSINESS WIRE)–CONMED Corporation (NASDAQ: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies London Healthcare Conference at 9:20 a.m. GMT (4:20 a.m. ET) on Wednesday, November 20, 2019 in London, UK. A live webcast of the presentation will be accessible through the “Investors” section…
DetailsSALT LAKE CITY–(BUSINESS WIRE)–As the outbreak of lung injuries and deaths associated with e-cigarettes, or vaping, continues to spread across the U.S., researchers at Intermountain Healthcare in Salt Lake City have effectively developed a best practice guide to quickly identify and treat patients who develop the new and potentially fatal respiratory injury, according to a…
DetailsWILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including: Credit Suisse 28th Annual Healthcare Conference in Scottsdale, Arizona on Tuesday, November 12th, at 10:20 a.m. MST (8:20 a.m. EST); Jefferies 2019 London Healthcare Conference in London, England on Thursday, November 21st, at 9:20…
DetailsSANTA CLARA, Calif.–(BUSINESS WIRE)–Golden Impressions Marketing, Inc. today announces it is expanding its operation from Denver to Silicon Valley to better serve local clients and be close to rapidly expanding markets. Additionally, Golden Impressions (GI) is announcing the expansion of its management team and the publishing of its new website. Proximity to Silicon Valley Silicon…
DetailsDUBLIN–(BUSINESS WIRE)–The “United States Legal Marijuana Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The country research report on United States legal marijuana market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts,…
DetailsCAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, presented a novel approach to producing human induced pluripotent stem cell (iPSC)-derived organoids at scale in an oral presentation on November 9th at the American Society of Nephrology (ASN) Kidney Week 2019…
DetailsCHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD.PR.A), a nationally recognized consumer cannabidiol (CBD) brand, announced today preliminary unaudited net sales for the fourth quarter of fiscal 2019 which ended September 30, 2019. “cbdMD’s unaudited net sales were $9.5 million for our last quarter of fiscal 2019, which was an increase of over…
DetailsLOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) (“MedMen” or the “Company”), a leading cannabis retailer with operations across the U.S., announces the opening of its latest Florida location in the city of Sarasota. This is the eighth of 12 locations MedMen plans to open in Florida this calendar year. The Company is licensed…
DetailsMONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company was honoured on November 8 at the Canadian Cannabis Awards Gala in Toronto with the Top Product Award in the High THC…
DetailsUPPER NYACK, N.Y.–(BUSINESS WIRE)–CreakyJoints®, a Global Healthy Living Foundation patient community, will present five posters, some in partnership with major academic institutions, at the 2019 ACR/ARP Annual Meeting in Atlanta, GA (Nov. 8-12, 2019) that speak to the decisions patients make when treating and tracking their arthritis. In the poster “Legal Matters: Attitudes Regarding Marijuana…
DetailsCAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company has initiated ILLUMINATE-C, a new global Phase 3 study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic in development for the treatment of primary hyperoxaluria type 1 (PH1). The study will enroll patients of all ages with advanced…
Details–(BUSINESS WIRE)–GOLDEN IMPRESSIONS Celebrating 20 years of service, Golden Impressions (GI) is a public relations, digital and content marketing services firm located in Denver and Silicon Valley. GI delivers high impact, purpose-driven marketing programs and solutions with a focus on tech, healthcare, government plus other vertical markets, including cannabis. GI’s mission is to support companies…
Details